Medicated skin care saw 2% value growth in 2010, which was slightly slower than the review period CAGR of 3%. The slower growth compared with the review period CAGR was mainly due to the revised Pharmaceutical Affairs Law implemented in 2009, restricting sales of Category 1 products, which are typically higher priced. This category includes ingredients such as acyclovir and miconazole nitrate, which were switched to OTC in 2007 and 2008, respectively. However, 2010's growth rate was still...

Euromonitor International's Medicated Skin Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Medicated Skin Care market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Medicated Skin Care in Japan
Euromonitor International
July 2011
List of Contents and Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Category Data
- Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 2 Daiichi Sankyo Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2010
- Hisamitsu Pharmaceutical Co Inc in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2010
- Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2010
- Otsuka Pharmaceutical Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 10 Otsuka Pharmaceutical Co Ltd: Key Facts
Summary 11 Otsuka Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 12 Otsuka Pharmaceutical Co Ltd: Competitive Position 2010
- Rohto Pharmaceutical Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 13 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 14 Rohto Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 15 Rohto Pharmaceutical Co Ltd: Competitive Position 2010
- Sato Pharmaceutical Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 16 Sato Pharmaceutical Co Ltd: Key Facts
Summary 17 Sato Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 18 Sato Pharmaceutical Co Ltd: Competitive Position 2010
- Ssp Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 19 SSP Co Ltd: Key Facts
Summary 20 SSP Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 21 SSP Co Ltd: Competitive Position 2010
- Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 22 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 23 Taisho Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 24 Taisho Pharmaceutical Co Ltd: Competitive Position 2010
- Takeda Chemical Industries Ltd in Consumer Health (japan)
- Strategic Direction
- Key Facts
Summary 25 Takeda Chemical Industries Ltd: Key Facts
Summary 26 Takeda Chemical Industries Ltd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 27 Takeda Chemical Industries Ltd: Competitive Position 2010
- Executive Summary
- Slow But Steady Recovery From Revised Pal Implementation
- Consumers Focus on Health Maintenance Rather Than Cure
- Competitive Environment Remained Stagnant
- Revised Pal Makes Only Small Impact on Retail Landscape
- Positive But Slower Growth Expected Over the Forecast Period
- Key Trends and Developments
- Adding Value Through New Formats and Convenience
- Desire for Healthy and Beautiful Living Continues
- Promoting Active Ageing
- Revised Pal Plan To Broaden Sales Channels A Flop
- Lack of Pharmacists Dampens Sales of Switched OTC Products
- Market Indicators
- Market Data
- Consumer Healthcare Registration and Classification
- Self-medication/self-care and Preventative Medicine
- Switches
Summary 28 OTC Healthcare Switches 2008-2010
- Definitions
Summary 29 Research Sources
List of Tables
- Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010
- Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
- Table 3 Acne Treatments by Format: % Value Breakdown 2005-2010
- Table 4 Medicated Skin Care Company Shares by Value 2006-2010
- Table 5 Medicated Skin Care Brand Shares by Value 2007-2010
- Table 6 Acne Treatments Brand Shares by Value 2007-2010
- Table 7 Hair Loss Treatments Brand Shares by Value 2007-2010
- Table 8 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
- Table 9 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015
- Table 10 Consumer Expenditure on Health Goods and Medical Services 2005-2010
- Table 11 Life Expectancy at Birth 2005-2010
- Table 12 Sales of Consumer Health by Category: Value 2005-2010
- Table 13 Sales of Consumer Health by Category: % Value Growth 2005-2010
- Table 14 Consumer Health Company Shares by Value 2006-2010
- Table 15 Consumer Health Brand Shares by Value 2007-2010
- Table 16 Penetration of Private Label by Category 2005-2010
- Table 17 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
- Table 18 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
- Table 19 Forecast Sales of Consumer Health by Category: Value 2010-2015
- Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

Pharmaceutical Market Research

Medicated Skin Care in Japan

Medicated Skin Care in Japan

Why buy this report?

Contents

Related products